Kyverna Therapeutics, Inc.: 10-Q filed 2025-08-12
What Kyverna Therapeutics, Inc. reported in its quarterly report filed 2025-08-12 (fiscal Q2 2025): 37 published measures, 107 facts as tagged in accession 0000950170-25-107321.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-08-12
- Fiscal period
- fiscal Q2 2025
- Accession
- 0000950170-25-107321 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Kyverna Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 226,508,000 | USD | |
| At 2024-12-31 | 304,645,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 42,131,000 | USD | |
| At 2024-12-31 | 38,058,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 184,377,000 | USD | |
| At 2025-03-31 | 224,010,000 | USD | |
| At 2024-12-31 | 266,587,000 | USD | |
| At 2024-06-30 | 333,509,000 | USD | |
| At 2024-03-31 | 360,991,000 | USD | |
| At 2023-12-31 | -131,397,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 53,440,000 | USD | |
| At 2024-12-31 | 96,621,000 | USD | |
| At 2024-06-30 | 131,618,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -42,081,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -86,716,000 | USD | 181 |
| 2025-01-01 to 2025-03-31 | -44,635,000 | USD | 90 |
| 2024-04-01 to 2024-06-30 | -28,803,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -55,496,000 | USD | 182 |
| 2024-01-01 to 2024-03-31 | -26,693,000 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -76,864,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -49,700,000 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 4,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 1,571,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -1,063,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 337,480,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 34,745,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -190,800,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -350,236,000 | USD | |
| At 2024-12-31 | -263,520,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 43,225,365 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 43,220,498 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 43,125,709 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 33,439,886 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 43,225,365 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 43,220,498 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 43,125,709 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 33,439,886 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.97 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -2.01 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.67 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -1.66 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.97 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -2.01 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.67 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -1.66 | USD/shares | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 2,162,000 | USD | |
| At 2024-12-31 | 3,347,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 4,679,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 3,562,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -44,410,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -91,818,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -33,435,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -62,793,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 214,327,000 | USD | |
| At 2024-12-31 | 290,601,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 39,789,000 | USD | |
| At 2024-12-31 | 33,756,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 9,917,000 | USD | |
| At 2024-12-31 | 4,624,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 44,410,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 91,818,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 33,435,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 62,793,000 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 35,816,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 73,249,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 27,321,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 49,797,000 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 43,244,930 | shares | |
| At 2024-12-31 | 43,214,918 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -20,000 | USD | |
| At 2024-12-31 | 105,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 5,049,000 | USD | |
| At 2024-12-31 | 6,468,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 6,374,000 | USD | |
| At 2024-12-31 | 7,019,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 4,212,000 | USD | |
| At 2024-12-31 | 3,672,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 4,053,000 | USD | |
| At 2024-12-31 | 2,836,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 2,650,000 | USD | |
| At 2024-12-31 | 4,622,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -42,100,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -86,841,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -28,839,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -55,537,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 8,594,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 18,569,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 6,114,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 12,996,000 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 1,016,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 1,012,000 | USD | 182 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 14,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 38,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 39,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 83,000 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -21,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -49,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -23,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -49,000 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 2,329,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 5,102,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 4,632,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 7,297,000 | USD | 182 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 37,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 82,000 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 5,193,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 967,000 | USD | 182 |
Inspect the source
- Entity
- Kyverna Therapeutics, Inc. / CIK 0001994702
- Captured
- 2026-09-21T17:37:57.733Z
- SEC response SHA-256
e3a9d4fead95b594ab9ebaedcee0f9b6962e0ff5a252aa0186e5785c98116ab3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001994702.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))